Idexx Laboratories (IDXX) Cash from Investing Activities (2009 - 2026)

Idexx Laboratories' Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$33.5 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 13.29% year-over-year to -$33.5 million; the TTM figure through Mar 2026 stood at -$140.2 million (down 8.05% YoY), while the FY2025 annual figure was -$136.2 million, up 34.2% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$33.5 million, down from -$28.1 million in the prior quarter.
• The five-year high for Cash from Investing Activities was -$27.4 million in Q3 2024, with the low at -$106.9 million in Q1 2024.
• The 5-year median for Cash from Investing Activities is -$33.6 million (2025), against an average of -$41.0 million.
• The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities slumped 170.67% in 2024, then surged 72.31% in 2025.
• Idexx Laboratories' Cash from Investing Activities stood at -$49.2 million in 2022, then jumped by 38.18% to -$30.4 million in 2023, then slumped by 30.91% to -$39.8 million in 2024, then advanced by 29.4% to -$28.1 million in 2025, then slipped by 19.25% to -$33.5 million in 2026.
• Business Quant data shows IDXX's Cash from Investing Activities at -$33.5 million in Q1 2026, -$28.1 million in Q4 2025, and -$44.9 million in Q3 2025.